
|Slideshows|April 5, 2019
7 New Drugs for Neurologists
Author(s)Julie Bowen
Here’s a brief look at therapies for neurological disorders that the FDA has approved within the past 6 months.
Advertisement
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Cladribine Tablets Reduce Treatment Switches, Outpatient Visits, and Health Care Costs in Multiple Sclerosis
2
Innovative Trial Employs Novel PET Imaging to Track Cladribine’s Effect on Microglial Activation
3
Comparative Study Reveals Psychiatric Comorbidities Common in MOGAD, MS, and NMOSD, With Distinct Timing Patterns
4
Myelin Protective Small Molecule Lucid-MS Shows Promising Early-Stage Data in Healthy Volunteers
5










